| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |